Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
657
-
Total 13F shares, excl. options
-
95.2M
-
Shares change
-
+272K
-
Total reported value, excl. options
-
$20.8B
-
Value change
-
+$79.1M
-
Put/Call ratio
-
0.36
-
Number of buys
-
266
-
Number of sells
-
-339
-
Price
-
$218.99
Significant Holders of RESMED INC - Common Stock (RMD) as of Q1 2023
763 filings reported holding RMD - RESMED INC - Common Stock as of Q1 2023.
RESMED INC - Common Stock (RMD) has 657 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.2M shares
of 146M outstanding shares and own 64.98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.5M shares), BlackRock Inc. (13.1M shares), FMR LLC (6.5M shares), STATE STREET CORP (6.29M shares), Capital World Investors (4.25M shares), WCM INVESTMENT MANAGEMENT, LLC (3.48M shares), GEODE CAPITAL MANAGEMENT, LLC (3.23M shares), CITADEL ADVISORS LLC (2.1M shares), Invesco Ltd. (1.94M shares), and NORTHERN TRUST CORP (1.75M shares).
This table shows the top 657 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.